☆ 4.2 Article

Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis

MEDICINA-LITHUANIA (2022)

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Thioredoxin Prevents Loss of UCP2 in Hyperoxia via MKK4-p38 MAPK-PGC1α Signaling and Limits Oxygen Toxicity

Somasundaram Raghavan et al.

Summary: The study aimed to investigate the role of UCP2 in reducing O-2(center dot-) production in the lung under normal or hyperoxia conditions. The results showed that high-concentration oxygen caused a decrease in UCP2 expression and an increase in lung O-2(center dot-) production. However, treatment with recombinant human thioredoxin or overexpression of Trx prevented the loss of UCP2 and reduced O-2(center dot-) generation in the lung.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Cytotoxicity, in silico predictions and molecular studies for androstane heterocycle compounds revealed potential antitumor agent against lung cancer cells

Mohamed A. Tantawy et al.

Summary: This study provides new molecular insights into the antiproliferative activity of six 3 beta-acetoxy-5 alpha-androstane heterocycle compounds against non-small-cell lung carcinoma (NSCLC). Compound 4 shows potential cytotoxicity on NSCLC cells and acts as a dual inhibitor of IL6/JAK2/STAT3 and tubulin formation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Add to Collection
Article Health Care Sciences & Services

Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)

Abdiel Absalon-Aguilar et al.

Summary: A triple-blind clinical trial was conducted to evaluate the safety and efficacy of colchicine treatment in 116 hospitalized severe COVID-19 patients. The study showed that colchicine had no effect on the primary outcome, days of ICU and hospital stays, and adverse events were similar between the colchicine and placebo groups. After colchicine treatment, patients had higher BUN levels and lower serum levels of IL-8, IL-12p70, and IL-17A.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Add to Collection
Review Environmental Sciences

CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target

Tapan Behl et al.

Summary: The study highlights the potential role of CD147 as an alternative entry receptor for SARS-CoV-2 in COVID-19 infection, with implications for various aspects of the disease such as elevated blood glucose levels, reduced risk in women, increased susceptibility in the elderly, and greater infection susceptibility in certain cell types.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Add to Collection
Article Pharmacology & Pharmacy

Colchicine attenuates renal ischemia-reperfusion-induced liver damage: implication of TLR4/NF-κB, TGF-β, and BAX and Bcl-2 gene expression

Azza Sayed Awad et al.

Summary: The study found that colchicine alleviated liver damage in rats caused by renal IRI through its anti-inflammatory, anti-apoptotic, and anti-fibrotic actions.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation

Li Wang et al.

Summary: Colchicine-containing nanoparticles, delivered through calcium carbonate nanoparticles, showed significant reduction in myocardial infarct size and myocardial fibrosis after acute MI, along with decreased levels of inflammatory cytokines. The nanoparticles also inhibited pyroptosis and inflammatory response by modulating macrophage polarization and suppressing the TLR4/NF kappa B/NLRP3 signal pathway.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Add to Collection
Article Medicine, General & Internal

Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID)

Domingo A. Pascual-Figal et al.

Summary: In the COL-COVID study, colchicine treatment did not improve the clinical status or inflammatory response in hospitalized COVID-19 patients compared to standard treatment. However, it may have a preventive effect on further clinical deterioration.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Add to Collection
Review Medicine, General & Internal

COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment

Anant Parasher

Summary: COVID-19, caused by the novel coronavirus SARS-CoV-2, has rapidly spread globally and presents in a spectrum of mild, moderate, and severe illness. Diagnosis is currently based on reverse-transcription PCR of nasopharyngeal and oropharyngeal swab samples, with treatment including ventilation, antipyretics, antivirals, antibiotics, and steroids.

POSTGRADUATE MEDICAL JOURNAL (2021)

Add to Collection
Article Biology

Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study

Marimuthu Ragavan Rameshkumar et al.

Summary: This study analyzed the inhibitory potential of flavonoid compounds against important protein targets of SARS-CoV-2 using computational approaches. Virtual screening and docking were conducted, leading to the identification of top 10 lead compounds against main protease, RNA-dependent RNA polymerase, and spike proteins. The study identified potent inhibitors with high docking scores and non-carcinogenic and non-mutagenic properties for further research against SARS-CoV-2.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection
Review Rheumatology

Anti-inflammatory therapy for COVID-19 infection: the case for colchicine

Aaron Z. Reyes et al.

Summary: The search for effective COVID-19 management strategies is ongoing, with colchicine showing promise in targeting multiple mechanisms associated with excessive inflammation. Outpatient treatment with colchicine could potentially reduce the need for hospitalization and mortality due to COVID-19, benefiting both resource-replete and resource-poor regions by reducing the demand for rare or expensive care resources.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection
Article Oncology

4'-O-Methylbroussochalcone B as a novel tubulin polymerization inhibitor suppressed the proliferation and migration of acute myeloid leukaemia cells

Ziying Liu et al.

Summary: The study identified that 4'-O-Methylbroussochalcone B inhibits proliferation and migration of AML cells by acting as a tubulin polymerization inhibitor through the MAPK and Wnt/beta-catenin pathways. It shows promise as a potential new drug for AML treatment.

BMC CANCER (2021)

Add to Collection
Article Medicine, Research & Experimental

The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease

Elisa Avolio et al.

Summary: The study found that the S protein of SARS-CoV-2 may lead to dysfunction and death of pericytes, potentially contributing to microvascular injury, and it activates the ERK1/2 pathway through the CD147 receptor, which could play a role in microvascular damage.

CLINICAL SCIENCE (2021)

Add to Collection
Article Multidisciplinary Sciences

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Goran Kokic et al.

Summary: Remdesivir is the only FDA-approved drug for treating COVID-19 patients, working by inhibiting the RNA-dependent RNA polymerase (RdRp) of coronaviruses. It hinders RNA synthesis and impairs proofreading by the viral 3'-exonuclease, leading to a stalled replication process.

NATURE COMMUNICATIONS (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Emerging Anti-Atherosclerotic Therapies

Anna Gluba-Brzozka et al.

Summary: Cardiovascular disease (CAD) is a major cause of morbidity and mortality in the western world, with atherosclerosis as a key factor. New preventive and therapeutic measures are needed as current drugs are insufficient to reduce atherosclerosis development effectively. Identifying new targets for anti-atherosclerotic drugs, especially focusing on inflammation, is a promising direction for future research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection
Article Medical Laboratory Technology

Colchicine, COVID-19 and hematological parameters: A meta-analysis

Musharraf Sarwar et al.

Summary: Colchicine has shown efficacy in reducing inflammatory biomarkers such as CRP, LDH, and D-dimer in moderate-to-severe COVID-19 patients, suggesting its potential as an adjunct to COVID-19 treatment. Additional monitoring of clinical and laboratory parameters in further trials is warranted.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Add to Collection
Article Biology

Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents

Vicky Mody et al.

Summary: The study identified potential drugs that target the pivotal protease 3-chymotrypsin like protease (3CLpro) for SARS-CoV-2 replication. Some of these drugs showed inhibitory effects on the enzyme activity, suggesting they could be useful in inhibiting SARS-CoV-2 replication.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

Colchicine and SARS-CoV-2: Management of the hyperinflammatory state

Antonio Vitiello et al.

Summary: The global COVID-19 pandemic is ongoing with the licensing of the first Sars-CoV-2 vaccine by the EMA in December 2020. Studies suggest that colchicine, an anti-inflammatory therapy, may be effective at modulating and controlling the inflammatory state associated with severe COVID-19 complications. It is important to conduct well-organized clinical studies to further explore the potential of colchicine in treating and preventing cytokine storms in patients with SARS-CoV-2 infection.

RESPIRATORY MEDICINE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

S-allylcysteine inhibits chondrocyte inflammation to reduce human osteoarthritis via targeting RAGE, TLR4, JNK, and Nrf2 signaling: comparison with colchicine

Zubeyir Elmazoglu et al.

Summary: The study found that S-allylcysteine (SAC) and colchicine can modulate the function of human osteoarthritis chondrocytes (OAC) by inhibiting redox-sensitive inflammatory signaling pathways.

BIOCHEMISTRY AND CELL BIOLOGY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

Colchicine and the heart

Massimo Imazio et al.

Summary: Colchicine, a unique anti-inflammatory agent, has shown potential in a range of cardiovascular conditions in recent clinical trials, in addition to its traditional use in gout and familial Mediterranean fever.

EUROPEAN HEART JOURNAL (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

PROACTIVE ANTI-INFLAMMATORY THERAPY WITH COLCHICINE IN THE TREATMENT OF ADVANCED STAGES OF NEW CORONAVIRUS INFECTION. THE FIRST RESULTS OF THE COLORIT STUDY

V. Yu. Mareev et al.

KARDIOLOGIYA (2021)

Add to Collection
Article Rheumatology

Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials

Kedar Gautambhai Mehta et al.

Summary: The meta-analysis findings suggest that the addition of colchicine to standard care regimen for patients with COVID-19 does not significantly reduce mortality, ventilatory support, ICU admission, length of hospital stay, or serious adverse events. There is a possibility of increased adverse events and diarrhea with colchicine treatment.

RMD OPEN (2021)

Add to Collection
Article Multidisciplinary Sciences

Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study

Lucio Manenti et al.

Summary: This study found that the use of colchicine in COVID-19 patients was associated with reduced mortality and accelerated recovery, which was further supported by changes in inflammatory markers.

PLOS ONE (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors

Yipeng Cao et al.

Summary: Studying the SARS-CoV-2 E protein is crucial for understanding the pathogenesis of the virus and plays a key role in disease treatment. While there are similarities between the SARS-CoV-2 and SARS-CoV E proteins, further specific research on the SARS-CoV-2 E protein is still needed.

PROTEIN SCIENCE (2021)

Add to Collection
Article Pharmacology & Pharmacy

Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens

Eleni Karatza et al.

Summary: Colchicine is being investigated for cardioprotection in COVID-19 patients, with no consensus on the appropriate dosage regimen. Simulations indicated that 0.5 mg twice daily administration of colchicine can be considered safe and effective, tailored to patients' needs in cases of clearance impairment.

XENOBIOTICA (2021)

Add to Collection
Article Cell Biology

Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE

Sofia Nolasco et al.

Summary: Colchicine is used to treat gout and prevent inflammatory diseases like pericarditis. Its anti-inflammatory action is achieved by inhibiting tubulin polymerization and affecting the activities of tubulin folding cofactors, particularly TBCA, TBCB, and TBCE. Manipulation of these activities impacts tubulin recycling and dynamics, leading to beneficial effects in treating inflammation.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection
Article Genetics & Heredity

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

Mehdi Shahgolzari et al.

Summary: SARS-CoV-2 directly interacts with host cells, inducing inflammation that leads to severe disease and impairs the immune system's ability to effectively respond to the virus.

GENE REPORTS (2021)

Add to Collection
Article Cell Biology

Microtubule inhibitors identified through nonbiased screening enhance DNA transfection efficiency by delaying p62-dependent ubiquitin recruitment

Megumi Tsuchiya et al.

Summary: Inhibiting p62/SQSTM1 receptor can increase DNA transfection efficiency, and microtubule inhibitors have positive effects in the presence of p62.

GENES TO CELLS (2021)

Add to Collection
Article Cell Biology

The potential role of neopterin in Covid-19: a new perspective

Hayder M. Al-kuraishy et al.

Summary: NPT is a member of pteridines group synthesized by macrophages, which is regarded as a macrophage stimulation indicator and immune response marker, with potential independent prognostic significance in Covid-19. Early elevation of NPT levels may indicate the activation status of inflammatory cells.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Add to Collection
Article Immunology

Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets

Noha A. Kamel et al.

Summary: The world is still grappling with COVID-19, a pandemic that has resulted in numerous deaths. Understanding SARS-CoV-2 cell entry mechanisms is crucial in combating the virus in this urgent situation.

VIRAL IMMUNOLOGY (2021)

Add to Collection
Article Critical Care Medicine

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

Jean-Claude Tardif et al.

Summary: The study aimed to investigate the effect of colchicine on the composite of COVID-19-related death or hospital admission. Among patients with PCR-confirmed COVID-19, colchicine led to a lower rate of the composite of death or hospital admission than placebo.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection
Article Critical Care Medicine

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Group Author Only

Summary: The study aimed to evaluate the efficacy and safety of colchicine in treating COVID-19 patients, but found that it did not reduce 28-day mortality, hospital stay duration, or risk of progressing to invasive mechanical ventilation or death.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection
Article Endocrinology & Metabolism

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

Jui-Hsia Weng et al.

Summary: The study demonstrates that the anti-inflammatory effects of colchicine are mediated indirectly through the release of hepatokines such as GDF15, rather than through direct action on immune cells. This suggests that the efficacy and safety of colchicine depend on its selective action on hepatocytes, revealing a new axis of liver-myeloid cell communication. Plasma GDF15 levels and myeloid cell SHP-1 activity may serve as useful pharmacodynamic biomarkers of colchicine action.

NATURE METABOLISM (2021)

Add to Collection
Review Microbiology

Coronavirus biology and replication: implications for SARS-CoV-2

Philip V'kovski et al.

Summary: This review discusses key aspects of coronavirus biology and their implications for SARS-CoV-2 infections, treatment, and prevention strategies. Understanding virus-host interactions at the molecular level is crucial for developing effective intervention strategies. Summarizing the discoveries of SARS-CoV-2 infection and comparing it with other coronaviruses will support future preparedness and combat strategies.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection
Article Rheumatology

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Maria Isabel Lopes et al.

Summary: Colchicine showed benefits in the treatment of COVID-19 patients by reducing the need for supplemental oxygen and length of hospitalisation. It did not necessarily reduce mortality, but was safe and well tolerated with the potential side effect of diarrhea.

RMD OPEN (2021)

Add to Collection
Review Rheumatology

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Mehmet Soy et al.

CLINICAL RHEUMATOLOGY (2020)

Add to Collection
Editorial Material Medicine, Research & Experimental

What Do We Know About Remdesivir Drug Interactions?

Katherine Yang

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Colchicine treatment impairs skeletal muscle mitochondrial function and insulin sensitivity in an age-specific manner

Bjorg Thiellesen Buch et al.

FASEB JOURNAL (2020)

Add to Collection
Review Immunology

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Article Medicine, General & Internal

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial

Spyridon G. Deftereos et al.

JAMA NETWORK OPEN (2020)

Add to Collection
Article Medicine, Research & Experimental

Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach

Syed Ovais Aftab et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection
Article Biochemistry & Molecular Biology

NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site

Dipanwita Das Mukherjee et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)

Add to Collection
Article Pharmacology & Pharmacy

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

Yasmin Abo-zeid et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Add to Collection
Review Cell Biology

Cytoskeleton-a crucial key in host cell for coronavirus infection

Zeyu Wen et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals

Daniel W. Kneller et al.

STRUCTURE (2020)

Add to Collection
Review Medicine, Research & Experimental

Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19

Jayanta Talukdar et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection
Review Respiratory System

SARS coronavirus 2: from genome to infectome

Meghana Rastogi et al.

RESPIRATORY RESEARCH (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach

Md Sorwer Alam Parvez et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Add to Collection
Article Infectious Diseases

A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection

Tegveer Sandhu et al.

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2020)

Add to Collection
Review Rheumatology

Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials

Sarah Stewart et al.

ARTHRITIS RESEARCH & THERAPY (2020)

Add to Collection
Review Immunology

How COVID-19 induces cytokine storm with high mortality

Shintaro Hojyo et al.

INFLAMMATION AND REGENERATION (2020)

Add to Collection
Article Microbiology

Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome

I-Yin Chen et al.

FRONTIERS IN MICROBIOLOGY (2019)

Add to Collection
Review Immunology

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Karen V. Swanson et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Add to Collection
Review Dermatology

Colchicine: an ancient drug with novel applications

B. Dasgeb et al.

BRITISH JOURNAL OF DERMATOLOGY (2018)

Add to Collection
Review Cell Biology

Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease

Ton Lisman

CELL AND TISSUE RESEARCH (2018)

Add to Collection
Review Virology

Microtubule Regulation and Function during Virus Infection

Mojgan H. Naghavi et al.

JOURNAL OF VIROLOGY (2017)

Add to Collection
Article Oncology

Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model

Seiji Itano et al.

MOLECULAR MEDICINE REPORTS (2017)

Add to Collection
Article Rheumatology

Update on colchicine, 2017

Anastasia Slobodnick et al.

RHEUMATOLOGY (2017)

Add to Collection
Review Rheumatology

Colchicine-Update on mechanisms of action and therapeutic uses

Ying Ying Leung et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)

Add to Collection
Article Multidisciplinary Sciences

Genetic drift of human coronavirus OC43 spike gene during adaptive evolution

Lili Ren et al.

SCIENTIFIC REPORTS (2015)

Add to Collection
Article Pharmacology & Pharmacy

Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension

Fan-Yen Lee et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)

Add to Collection
Review Toxicology

Colchicine poisoning: the dark side of an ancient drug

Yaron Finkelstein et al.

CLINICAL TOXICOLOGY (2010)

Add to Collection
Article Multidisciplinary Sciences

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?

Bharat B. Aggarwal et al.

NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)

Add to Collection
Editorial Material Cell Biology

Autophagy revisited

Daniel J. Klionsky

AUTOPHAGY (2008)

Add to Collection
Article Rheumatology

Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation

George Nuki

Current Rheumatology Reports (2008)

Add to Collection
Review Biochemistry & Molecular Biology

Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway

RJ Orton et al.

BIOCHEMICAL JOURNAL (2005)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.